Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety

This study has been completed.
Information provided by:
Wyeth is now a wholly owned subsidiary of Pfizer Identifier:
First received: October 17, 2005
Last updated: March 14, 2007
Last verified: March 2007
The purpose of this study is to assess the prevalence of Major Depression and/or Anxiety Disorder in patients consulting the General Practitioner with acute or chronic painful physical symptoms and to identify risk factors.

Anxiety Disorder

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Official Title: An Observational Study on the Presence of Depression and/or Anxiety Disorder in Patients Consulting the General Practitioner With Painful Physical Symptoms in Belgium and Luxemburg.

Resource links provided by NLM:

Further study details as provided by Wyeth is now a wholly owned subsidiary of Pfizer:

Estimated Enrollment: 2560
Study Start Date: November 2005

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Outpatient must be at least 18 years of age
  • Consulting a General Practitioner for painful physical symptoms
  • Written informed consent

Exclusion Criteria:

  • Patient is unable to understand and comply with procedures of the study
  • Patient is unable to complete the patient ratings
  • Patient has an acute pain with an obvious cause
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00241397

  Show 91 Study Locations
Sponsors and Collaborators
Wyeth is now a wholly owned subsidiary of Pfizer
Study Director: Medical Monitor, MD Wyeth is now a wholly owned subsidiary of Pfizer
Principal Investigator: Trial Manager For Belgium,
  More Information Identifier: NCT00241397     History of Changes
Other Study ID Numbers: 0600B1-102003 
Study First Received: October 17, 2005
Last Updated: March 14, 2007
Health Authority: Belgium: Institutional Review Board

Keywords provided by Wyeth is now a wholly owned subsidiary of Pfizer:
anxiety disorder

Additional relevant MeSH terms:
Anxiety Disorders
Depressive Disorder
Behavioral Symptoms
Mental Disorders
Mood Disorders processed this record on May 26, 2016